Both in Pharmaceuticals
Aktis Oncology vs CryoPort
Over the past year AKTS returned −34.9% and CYRX returned +53.7%; their daily moves had a correlation of 0.24.
AKTS −34.9% CYRX +53.7%Growth of $1, one year, split-adjusted
| Metric | AKTS | CYRX |
|---|---|---|
| Price | $14.59 | $16.23 |
| Market cap | $811.5M | $822.0M |
| Today | −8.41% | −6.13% |
| 1 month | −21.2% | −6.9% |
| 6 months | −23.2% | +59.0% |
| Year to date | — | +69.1% |
| 1 year | — | +80.3% |
| Revenue growth (YoY) | — | +7.7% |
| Gross margin | 100.0% | 46.6% |
| Net margin | −713.5% | −20.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 4.4× |
| Net cash | $517.3M | $208.7M |
| Dividend yield | — | — |
| Volatility (60d) | 55.1% | 40.4% |
| Short % of float | 18.3% | 5.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).